Scancell Holdings Plc BLOCK LISTING SIX MONTHLY RETURN (2924P)

TIDMSCLP

RNS Number : 2924P

Scancell Holdings Plc

16 February 2021

Scancell Holdings Plc

("Scancell" or the "Company")

BLOCK LISTING SIX MONTHLY RETURN

Date: 16 February 2021

 
 Name of applicant:                     Scancell Holdings plc 
 Name of scheme:                        Convertible Loan Notes Shares 
                                       ------------------------------------------- 
 Period of return:            From:     12 August 2020     To:   15 February 2021 
                             --------  -----------------  ----  ------------------ 
 Number of securities                   96,774,193 ordinary shares of GBP0.001 
  originally admitted at                 each 
  date of admission                      12 August 2020 
                                       ------------------------------------------- 
 Balance of unallotted                  96,774,193 ordinary shares of GBP0.001 
  securities under scheme(s)             each 
  from previous return: 
                                       ------------------------------------------- 
 Plus: The amount by which              Nil 
  the block scheme(s) has 
  been increased since 
  the date of the last 
  return (if any increase 
  has been applied for): 
                                       ------------------------------------------- 
 Less: Number of securities             69,719,566 ordinary shares of GBP0.001 
  issued/allotted under                  each 
  scheme(s) during period: 
                                       ------------------------------------------- 
 Equals: Balance under                  27,054,627 ordinary shares of GBP0.001 
  scheme(s) not yet issued/allotted      each 
  at end of period: 
                                       ------------------------------------------- 
 
 
 
 Name of contact:                Dr Cliff Holloway, CEO 
 Telephone number of contact:    [phone] 
                                ----------------------- 
 

For Further Information:

 
 Scancell Holdings plc 
                                          [phone] 
 Dr John Chiplin, Chairman                 1000 
 Dr Cliff Holloway, CEO 
 
 Panmure Gordon (UK) Limited 
 Freddy Crossley/Emma Earl (Corporate     [phone] 
  Finance)                                 2500 
 Rupert Dearden (Corporate Broking) 
 
 FTI Consulting 
                                          [phone] 
 Simon Conway/Natalie Garland-Collins      1000 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRZQLFFFLLEBBV

(END) Dow Jones Newswires

February 16, 2021 10:00 ET (15:00 GMT)